Good MorningEquities fell hard right from the open on Monday with the S&P 500 down more than 2.0% at the low of the day and the other major indices in similar straits. The NASDAQ Composite fell nearly 3.0% at the low of the session on growing fear of rising interest rates. Not only is the pace of inflation high but the yield on the 10-year treasury notes has begun to spike again as well. A spike in treasury yields typically foreshadows higher interest rates from the Fed and those higher rates are long overdue.
The decline in equities could linger until the end of the week. This week the market is looking for a key read on inflation that is due out Friday morning. The PCE price index is expected to show a decline in the pace of inflation on a month-to-month basis but not enough to slow the impact of inflation on corporate profits. If the PCE price index comes in above expectation the S&P 500 could fall below key support at 4315 and go deeper into correction territory.
Featured: Sell these "safe" blue chips immediately (Ad) 
|
Communication Services | | Digital adtech platform The Trade Desk (NASDAQ: TTD) stock has been selling off since peaking at $97.28 post-10-for-1 stock split as the pandemic spawned a digital advertising surge. With the reopening trend accelerating with the spread of COVID-19 vaccinations, advertisers are stepping up marketing... Read the Full Story |
|
From Our Partners | | Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. | | Watch the full story and see the verified track record for yourself |
|
Consumer Staples | |
Kraft Heinz Is A Tasty Treat For Dividend Growth Investors
We've been interested in The Kraft Heinz Company (NASDAQ: KHC) for several years now and it looks like another great time to buy some shares. We've compiled a list of 7 factors that make this stock a highly attractive target now and for ... Read the Full Story |
|
Healthcare | |
Small-cap stocks are loosely defined as companies with a market capitalization of less than $2 billion dollars. When they are compared to large- and mid-cap companies, small-cap stocks are typically seen as having better growth potential.
By nature, small-cap stocks are subject to volatile price ... Read the Full Story |
|
From Our Partners | | Moderna's stock doubled in a single day after its cancer vaccine hit key Phase 3 goals, and Merck jumped too. But according to a former Steve Cohen fund manager, the next big opportunity is not Moderna or Merck.
It is a different kind of company tied to a technology already backed by Elon Musk, Sam Altman, Jeff Bezos, and Peter Thiel. Nvidia's Jensen Huang says it will have a dramatic impact on daily life, while Anthropic's CEO believes it could unlock a century of medical progress in just ten years.
Nature Magazine estimates its potential value at $367 trillion globally, and it is already rolling out across the United States. | | Click here to learn about this new era of medical technology |
|
Technology | | Technology service provider Endava (NYSE: DAVA) advanced in early trade Tuesday after the company reported better-than-expected fiscal fourth-quarter results.
The company specializes in assisting clients in various verticals, including financial services and payments, technology, media, logistics, ... Read the Full Story |
|
Markets | |
Highly Valued IHS Markit Returns To Earth
IHS Markit (NYSE: INFO) might be merged with S&P Global and it might not. That deal is under regulatory scrutiny right now which means investors need to remain wary. The Q3 results were good but marred by a glaring issue that has shares down more tha... Read the Full Story |
|
From Our Partners | | Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. | | Discover the gold income fund before the next payout date |
|
Consumer Discretionary | | With treasury yields heading higher and a hawkish Fed meeting last week, investors should be prepared for a rotation back into value stocks in the coming sessions. Many of these moves have already started to occur and while it's hard to predict just how long the rotation lasts, it’s still a sm... Read the Full Story |
|
Markets | |
I don't know about you, but I've sure noticed how much more expensive groceries have become lately. Suddenly, I'm paying $130 for a few simple groceries. A couple of years ago, those same groceries would have cost me just $90.
At first, I wondered if that was reality or just my perception, but t... Read the Full Story |
|
Markets | |
Cup and handles, head and shoulders, wedges, triangles, pennants, flags, and doubles tops, oh my! Unless you’re familiar with technical analysis, these may sound like a new line of decorative housewares.
They are actually types of stock price patterns that help guide investors’ buy an... Read the Full Story |
|
Industrials | |
Once a group that could seemingly only go up, electric vehicle (EV) stocks have had a rough ride in 2021. First it was fears of rising rates and the corresponding impact on companies with high valuations. More recently, it has been doubts about the viability of the Biden administration's infrastru... Read the Full Story |
|
Healthcare | |
Aurora Cannabis Capitulates On The Recreational Market
Aurora Cannabis (NYSE: ACB) is shifting gears and we like it. After years of fruitless effort spent on wild growth campaigns chasing the consumer dollar, the company has decided to focus on the medical end of the business. While Aurora will m... Read the Full Story |
|
The Early Bird Stock Of The Day iShares 3-7 Year Treasury Bond ETF (the Fund), formerly iShares Barclays 3-7 Year Treasury Bond Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the Barclays Capital U.S. 3-7 Year Treasury Bond Index (the Index). The Index measures the performance of public obligations of the United States Treasury that have a remaining maturity of greater than or equal to three years and less than seven years. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund's investment advisor is BlackRock Fund Advisors. | | View Today's Stock Pick |
|
